In vitro and in vivo experiments further validated that CNPY3 knockdown enhanced CC cell sensitivity to 5-fluorouracil, as evidenced by reduced IC50 values in cell viability assays and enhanced tumor growth suppression in 5-FU-treated xenograft models. This evidence concerns the gene CNPY3 and neoplasm.